Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

Cervera, R., Piette, J., Font, J., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou‐Griva, I., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10187 · Cited by 2,156

The Antiphospholipid Syndrome

Levine, J. S., Branch, D. W., & Rauch, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra002974 · Cited by 1,524

Update of the guidelines for lupus anticoagulant detection

PENGO, V., TRIPODI, A., REBER, G., RAND, J. H., ORTEL, T. L., GALLI, M., & DE GROOT, P. G. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03555.x · Cited by 1,197

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V, Jacobsen, S., Zeher, M. M., Tarr, T., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204838 · Cited by 974

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972

High plasma levels of factor VIII and the risk of recurrent venous thromboembolism

Kyrle, P. A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K., & Eichinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430702 · Cited by 763

In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant

Combes, V., Simon, A.-C., Grau, G. E., Arnoux, D., Camoin‐Jau, L., Sabatier, F., Mutin, M., Sanmarco, M., Sampol, J., & Dignat‐George, F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4985 · Cited by 731

A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

FINAZZI, G., MARCHIOLI, R., BRANCACCIO, V., SCHINCO, P., WISLOFF, F., MUSIAL, J., BAUDO, F., BERRETTINI, M., Testa, S., D'ANGELO, A., et al. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01340.x · Cited by 585

The Risk of Recurrent Venous Thromboembolism in Men and Women

Kyrle, P. A., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A., & Eichinger, S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032959 · Cited by 477

Antiphospholipid Antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke

(2004) · JAMA · doi:10.1001/jama.291.5.576 · Cited by 478

Epidemiology of the Antiphospholipid Antibody Syndrome

Petri, M. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0409 · Cited by 468

Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-11-3334 · Cited by 413

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo controlled trial in asymptomatic antiphospholipid antibody-positive individuals.

Erkan, D., Harrison, M. J., Levy, R., Peterson, M., Petri, M., Sammaritano, L., Unalp‐Arida, A., Vilela, V., Yazici, Y., & Lockshin, M. D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22663 · Cited by 401

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies

Tektonidou, M. G., Laskari, K., Panagiotakos, D. B., & Moutsopoulos, H. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24232 · Cited by 356

Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: Antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus

Amoura, Z., Koutouzov, S., Chabre, H., Cacoub, P., Amoura, I., Musset, L., Bach, J., & Pietté, J. C. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1 · Cited by 243

Antiphospholipid antibodies and thrombosis

Greaves, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10362-8 · Cited by 300

Systemic lupus erythematosus in three ethnic groups: III A comparison of characteristics early in the natural history of the LUMINA cohort

Alarcón, G. S., Friedman, A., Straaton, K. V., Moulds, J. M., LISSE, J. R., Bastian, H. M., McGwin, G., Bartolucci, A. A., Roseman, J. M., & Reveille, J. D. (1999) · Lupus · doi:10.1191/096120399678847704 · Cited by 309

Mutations in Coagulation Factors in Women with Unexplained Late Fetal Loss

Martinelli, I., Taioli, E., Cetin, I., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431405 · Cited by 307

Diagnosis and classification of the antiphospholipid syndrome

Gómez-Puerta, J. A., & Cervera, R. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.006 · Cited by 301

Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults

Font, J., Cervera, R., Espinosa, G., et al. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.8.456 · Cited by 302

The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease

STAIN, M., Schönauer, V., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A., Kyrle, P. A., & Eichinger, S. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01648.x · Cited by 299

Platelet microparticles: a wide-angle perspective

Horstman, L. L., & Ahn, Y. S. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00044-4 · Cited by 300

Guidelines On The Investigation and Management Of The Antiphospholipid Syndrome

Greaves, M., Cohen, H., Machin, S. J., & Mackie, I. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02069.x · Cited by 294

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

Cervera, R., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Kiss, E., Zeher, M. M., Tincani, A., Kontopoulou-Griva, I., Galeazzi, M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093179 · Cited by 286

A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L‐asparaginase

Mitchell, L. G., & and the PARKAA Group (2003) · Cancer · doi:10.1002/cncr.11042 · Cited by 270

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

Knight, J. S., Branch, D. W., & Ortel, T. L. (2023) · BMJ · doi:10.1136/bmj-2021-069717 · Cited by 299

Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism

Novacek, G., Weltermann, A., Sobala, A., Tilg, H., Petritsch, W., Reinisch, W., Mayer, A., Haas, T., Kaser, A., Feichtenschlager, T., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.026 · Cited by 265

Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events

Otomo, K., Atsumi, T., Amengual, O., Fujieda, Y., Kato, M., Oku, K., Horita, T., Yasuda, S., & Koike, T. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33340 · Cited by 254

Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long‐term outcome

Tektonidou, M. G., Sotsiou, F., Nakopoulou, L., Vlachoyiannopoulos, P. G., & Moutsopoulos, H. Μ. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20433 · Cited by 253

Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression

Cuadrado, M. J., López-Pedrera, C., Khamashta, M. A., Camps, M. T., Tinahones, F. J., Torres, A., Hughes, G. R. V., & Velasco, F. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400509 · Cited by 232

Pulmonary embolism: update on management and controversies

Duffett, L. D., Castellucci, L. A., & Forgie, M. A. (2020) · BMJ · doi:10.1136/bmj.m2177 · Cited by 256

Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study

Küçükkaya, R. D., Hacıhanefioğlu, A., Yenerel, M. N., Turgut, M., Keskin, H. L., Nalçacı, M., & İnanç, M. (2001) · Blood · doi:10.1182/blood.v98.6.1760 · Cited by 225

Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis

Pabinger, I., Grafenhofer, H., Kaider, A., Kyrle, P. A., Quehenberger, P., Mannhalter, C., & Lechner, K. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01307.x · Cited by 223

Complement activation in patients with primary antiphospholipid syndrome

Oku, K., Atsumi, T., Bohgaki, M., Amengual, O., Kataoka, H., Horita, T., Yasuda, S., & Koike, T. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.090670 · Cited by 219

TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy

Perelló, A., García‐Pagán, J. C., Gilabert, R., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30274 · Cited by 218

Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis

Arnaud, L., Mathian, A., Ruffatti, A., Erkan, D., Tektonidou, M., Cervera, R., Forastiero, R., Pengo, V., Lambert, M., Martinez-Zamora, M. A., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.014 · Cited by 215

Practical applications of snake venom toxins in haemostasis

Marsh, N., & Williams, V. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.02.016 · Cited by 217

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study

Ruffatti, A., Tonello, M., Visentin, M. S., Bontadi, A., Hoxha, A., Carolis, S. D., Botta, A., Salvi, S., Nuzzo, M. D., Rovere, P. Q., et al. (2011) · Rheumatology · doi:10.1093/rheumatology/ker139 · Cited by 214

Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis

Alba, P. B., Bento, L., Cuadrado, M. J., Karim, Y., Tungekar, M. F., Abbs, I., Khamashta, M. A., D’Cruz, D. P., & Hughes, G. R. V. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.6.556 · Cited by 213

Risk factors for thrombophilia in extrahepatic portal vein obstruction†

Primignani, M., Martinelli, I., Bucciarelli, P., et al. (2005) · Hepatology · doi:10.1002/hep.20591 · Cited by 207

Hyperhomocysteinemia in cerebral vein thrombosis

Martinelli, I., Battaglioli, T., Pedotti, P., Cattaneo, M., & Mannucci, P. M. (2003) · Blood · doi:10.1182/blood-2003-02-0443 · Cited by 203

Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF‐κB/Rel proteins via the p38 mitogen‐activated protein kinase pathway, and of the MEK‐1/ERK pathway

López-Pedrera, C., Buendía, P., Cuadrado, M. J., Siendones, E., Aguirre, M. A., Barbarroja, N., Montiel‐Duarte, C., Torres, A., Khamashta, M. A., & Velasco, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21549 · Cited by 203

Mannose-Binding Lectin Variant Alleles and the Risk of Arterial Thrombosis in Systemic Lupus Erythematosus

Øhlenschlæger, T. F., Garred, P., MADSEN, H. O., & Jacobsen, S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033122 · Cited by 197

How we diagnose the antiphospholipid syndrome

Giannakopoulos, B., Passam, F. H., Ioannou, Y., & Krilis, S. A. (2008) · Blood · doi:10.1182/blood-2007-12-129627 · Cited by 187

Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?

To, C. H., & Petri, M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21414 · Cited by 188

Risk Factors and Recurrence Rate of Primary Deep Vein Thrombosis of the Upper Extremities

Martinelli, I., Battaglioli, T., Bucciarelli, P., Passamonti, S. M., & Mannucci, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000137123.55051.9b · Cited by 187

Diagnosis and management of the antiphospholipid syndrome

Chaturvedi, S., & McCrae, K. R. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.07.006 · Cited by 195

Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study.

Ruffatti, A., Del Ross, T., Ciprian, M., Bertero, M. T., Salvatore, S., Scarpato, S., Montecucco, C., Rossi, S., Caramaschi, P., Biasi, D., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.142042 · Cited by 184

International consensus guidelines on anticardiolipin and anti–β 2 ‐glycoprotein I testing: Report from the 13th International Congress on Antiphospholipid Antibodies

Lakos, G., Favaloro, E. J., Harris, E. N., Meroni, P. L., Tincani, A., Wong, R. C. W., & Pierangeli, S. S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33349 · Cited by 182

Coagulation and Bleeding Disorders: Review and Update

Triplett, D. A. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.8.1260 · Cited by 182

‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010

Pierangeli, S., de Groot, P. G., Dlott, J. S., Favaloro, E. J., Harris, E., Lakos, G., Ortel, T. L., Meroni, P. L., Otomo, K., Pengo, V., et al. (2011) · Lupus · doi:10.1177/0961203310395055 · Cited by 179

Epileptic seizures in systemic lupus erythematosus

Appenzeller, S., Cendes, F., & Costallat, L. T. L. (2004) · Neurology · doi:10.1212/01.wnl.0000144178.32208.4f · Cited by 177

A cross-sectional study evaluating post-thrombotic syndrome in children

Kuhle, S., Koloshuk, B., Marzinotto, V., et al. (2003) · Thrombosis Research · doi:10.1016/j.thromres.2003.09.008 · Cited by 171

Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study

Galli, M., Borrelli, G., Jacobsen, E. M., Marfisi, R. M., Finazzi, G., Marchioli, R., Wisloff, F., Marziali, S., Morboeuf, O., & Barbui, T. (2007) · Blood · doi:10.1182/blood-2007-01-066043 · Cited by 170

A Common Mutation in the Methylenetetrahydrofolate Reductase Gene (C677T) Increases the Risk for Deep-Vein Thrombosis in Patients With Mutant Factor V (Factor V:Q 506 )

Cattaneo, M., Tsai, M. Y., Bucciarelli, P., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1662 · Cited by 168

Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke

Bushnell, C., & Goldstein, L. B. (2000) · Stroke · doi:10.1161/01.str.31.12.3067 · Cited by 165

Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome

Warkentin, T. E., Aird, W. C., & Rand, J. H. (2003) · Hematology · doi:10.1182/asheducation-2003.1.497 · Cited by 162

Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease

Pego‐Reigosa, J. M., & Isenberg, D. A. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken260 · Cited by 162

Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis

Moroni, G. L., Ventura, D., Riva, P., Panzeri, P., Quaglini, S., Banfi, G., Simonini, P., Bader, R., Meroni, P. L., & Ponticelli, C. E. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.09.011 · Cited by 153

Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies

Espinosa, G., Bucciarelli, S., Cervera, R., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.007245 · Cited by 154

Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial

Stephenson, M. D., Kutteh, W. H., Purkiss, S., Librach, C. L., Schultz, P., Houlihan, E., & Liao, C. (2010) · Human Reproduction · doi:10.1093/humrep/deq179 · Cited by 152

Long-Term Evaluation of the Risk of Recurrence After Cerebral Sinus-Venous Thrombosis

Martinelli, I., Bucciarelli, P., Passamonti, S. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.927046 · Cited by 151

Neuropsychiatric lupus syndromes

Afeltra, A., Garzia, P., Mitterhofer, A. P., Vadacca, M., Galluzzo, S., Porto, F. D., Finamore, L., Pascucci, S., Gasparini, M., Laganà, B., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000058904.94330.a7 · Cited by 149

Primary Sjögren Syndrome

Ramos‐Casals, M., Font, J., García‐Carrasco, M., et al. (2002) · Medicine · doi:10.1097/00005792-200207000-00004 · Cited by 148

Recent Guidelines and Recommendations for Laboratory Detection of Lupus Anticoagulants

Moore, G. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1364185 · Cited by 149

Clinical significance of lupus anticoagulants in children

Male, C., Lechner, K., Eichinger, S., et al. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70416-6 · Cited by 144

Treatment of Antiphospholipid Antibody Syndrome (APS) in Pregnancy: A Randomized Pilot Trial Comparing Low Molecular Weight Heparin to Unfractionated Heparin

Stephenson, M. D., Ballem, P. J., Tsang, P., Purkiss, S., Ensworth, S., Houlihan, E., & Ensom, M. H. H. (2004) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30644-2 · Cited by 140

Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia

Andrew, M. E., Hanna, K., Abshire, T. C., et al. (2003) · Thrombosis and Haemostasis · doi:10.1160/th02-11-0283 · Cited by 141

Diagnosis of antiphospholipid syndrome in routine clinical practice

Gardiner, C., Hills, J., Machin, S., & Cohen, H. (2013) · Lupus · doi:10.1177/0961203312460722 · Cited by 131

Laboratory Investigation of Thrombophilia

Tripodi, A., & Mannucci, P. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.9.1597 · Cited by 130

The Antiphospholipid Syndrome

Rand, J. H. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152412 · Cited by 128

Persistent Antiphospholipid Antibody (APL) in Asymptomatic Carriers as a Risk Factor for Future Thrombotic Events: A Nationwide Prospective Study

Mustonen, P., Lehtonen, K. V., Javela, K., & Puurunen, M. (2014) · Lupus · doi:10.1177/0961203314545410 · Cited by 127

A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus

Avčin, T., Benseler, S. M., Tyrrell, P. N., Čučnik, S., & Silverman, E. D. (2008) · Arthritis Care & Research · doi:10.1002/art.23334 · Cited by 127

Cerebral and corpus callosum atrophy in systemic lupus erythematosus

Appenzeller, S., Rondina, J. M., Li, L. M., Costallat, L. T. L., & Cendes, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21271 · Cited by 126

Hippocampal atrophy in systemic lupus erythematosus

Appenzeller, S., Carnevalle, A. D., Li, L. M., Costallat, L. T. L., & Cendes, F. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.049486 · Cited by 123

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort

Radin, M., Sciascia, S., Erkan, D., Pengo, V., Tektonidou, M. G., Ugarte, A., Meroni, P. L., Ji, L., Belmont, M. H., Cohen, H., et al. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.04.009 · Cited by 121

High plasma levels of factor VIII and risk of recurrence of venous thromboembolism

Cristina, L., Cosmi, B., Cini, M., Frascaro, M., Guazzaloca, G., & Palareti, G. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04795.x · Cited by 119

Budd-Chiari Syndrome Secondary to Antiphospholipid Syndrome

Espinosa, G., Font, J., García‐Pagán, J. C., Tàssies, D., Reverter, J. C., Gaig, C., Cervantes, F., Cervera, R., Bosch, J., & Ingelmo, M. (2001) · Medicine · doi:10.1097/00005792-200111000-00001 · Cited by 112

The Varicella-Autoantibody Syndrome

Josephson, C. D., Nuss, R., Jacobson, L. J., et al. (2001) · Pediatric Research · doi:10.1203/00006450-200109000-00009 · Cited by 116

Differential Effects of Anti–β2-Glycoprotein I and Antiprothrombin Antibodies on the Anticoagulant Activity of Activated Protein C

Galli, M., Ruggeri, L., & Barbui, T. (1998) · Blood · doi:10.1182/blood.v91.6.1999 · Cited by 116

Late-onset systemic lupus erythematosus: clinical features, course, and prognosis

Lucic, A. T., Petrović, R., Radak-Perović, M., Milovanovic, D. R., Milovanovic, J. R., Živanović, S., Pantović, S., & Veselinović, M. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2238-y · Cited by 114

Lupus Anticoagulant (LAC) Testing in Patients with Inflammatory Status: Does C-Reactive Protein Interfere with LAC Test Results?

Schouwers, S. M. E., Delanghe, J. R., & Devreese, K. M. J. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.09.001 · Cited by 115

Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment

Tripodi, A., de Groot, P. G., & Pengo, V. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02362.x · Cited by 114

Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome

Ruffatti, A., Calligaro, A., Hoxha, A., Trevisanuto, D., Ruffatti, A., Gervasi, M. T., Cuffaro, S., Pengo, V., & Punzi, L. (2010) · Arthritis Care & Research · doi:10.1002/acr.20098 · Cited by 114

Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia

Glueck, C. J., Aregawi, D., Goldenberg, N., et al. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2004.09.011 · Cited by 113

Antiprothrombin antibodies detected in two different assay systems

Atsumi, T., Koike, T., Hughes, G. R. V., Khamashta, M. A., & Bertolaccini, M. L. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-06-0382 · Cited by 113

Thromboembolism in paediatric lupus patients

Levy, D. M., Massicotte, M. P., Harvey, E. A., et al. (2003) · Lupus · doi:10.1191/0961203303lu458oa · Cited by 112

Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence

Lechner, D., Wiener, C., Weltermann, A., Eischer, L., Eichinger, S., & Kyrle, P. A. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02998.x · Cited by 111

Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis

Appenzeller, S., Zeller, C. B., Annichino-Bizzachi, J., et al. (2004) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2004.10.004 · Cited by 111

The Relationship of Antiphospholipid Antibodies to Thromboembolic Events in Pediatric Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study

Berube, C., Mitchell, L. G., Silverman, E. D., David, M., Saint‐Cyr, C., Laxer, R. M., Adams, M., Vegh, P., & Andrew, M. E. (1998) · Pediatric Research · doi:10.1203/00006450-199809000-00014 · Cited by 108

Predictors of Long-Term Recurrent Vascular Events After Ischemic Stroke at Young Age: The Italian Project on Stroke in Young Adults

Pezzini, A., Grassi, M., Lodigiani, C., Patella, R., Gandolfo, C., Zini, A., DeLodovici, M., Paciaroni, M., Sette, M. D., Toriello, A., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005663 · Cited by 91

Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation

Schett, G. A., Steiner, G. E., & Smolen, J. S. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199808)41:8 · Cited by 44

Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity: A European multicentre retrospective study

Salvan, E., Ross, T. D., Gerosa, M., Andreoli, L., Maina, A., Alijotas-Reig, J., Carolis, S. D., Mekinian, A., Bertero, M. T., Canti, V., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-03-0191 · Cited by 108

Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients

Appenzeller, S., Faria, A. V., Li, L. M., Costallat, L. T. L., & Cendes, F. (2008) · Annals of Neurology · doi:10.1002/ana.21483 · Cited by 108

Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study

Gris, J., Bouvier, S., Molinari, N., Galanaud, J. ‐., Cochery-Nouvellon, É., Mercier, É., Fabbro-Péray, P., Balducchi, J.-P., Marès, P., Quéré, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-381913 · Cited by 108

Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy

Ganzevoort, W., Rep, A., de Vries, J. I. P., Bonsel, G. J., & Wolf, H. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.02.012 · Cited by 107

Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus

Karassa, F. B., Ioannidis, J. P. A., Boki, K. A., Touloumi, G., Argyropoulou, M. I., Strigaris, K., & Moutsopoulos, H. Μ. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00603-3 · Cited by 106

The global anti-phospholipid syndrome score in primary APS

Sciascia, S., Sanna, G., Murru, V., Roccatello, D., Khamashta, M. A., & Bertolaccini, M. L. (2015) · Rheumatology · doi:10.1093/rheumatology/keu307 · Cited by 107

Assays for Measuring Rivaroxaban: Their Suitability and Limitations

Lindhoff‐Last, E., Samama, M. M., Ortel, T. L., Weitz, J. I., & Spiro, T. E. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181f2f264 · Cited by 157

Rivaroxaban for Thromboprophylaxis in Patients with Antiphospholipid Syndrome

Park, J. H., Song, J. S., & Choi, S. T. (2017) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2017.24.2.108 · Cited by 1

Developing Deep Venous Thrombosis while on Rivaroxaban: A Review of Rivaroxaban

Al-Khafaji, R. A. (2020) · Clinical Case Reports · doi:10.37421/jccr.2020.10.1365 · Cited by 1

Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?

Yates, S. G., Smith, S., Tharpe, W., Shen, Y.-M., & Sarode, R. (2016) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.06.005 · Cited by 18

Antiphospholipid and Thrombosis Syndromes

Bick, R. L., & Baker, W. (1994) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1001885 · Cited by 57